Biological Compounds and the Next Growth Frontier
For decades, compound management focused on small molecules—synthetic chemicals stored in vials, screened for activity against biological targets. But the pharmaceutical industry has shifted, and biologics now dominate pipelines. Antibodies, proteins, peptides, and cell-based therapies require different storage conditions, different tracking systems, and different expertise. This shift is...
0 التعليقات 0 المشاركات 3 مشاهدة 0 معاينة